Related Experiment Video
Updated: Sep 10, 2025
10:21
Developing Photosensitizer-Cobaloxime Hybrids for Solar-Driven H2 Production in Aqueous Aerobic Conditions
Published on: October 5, 2019
8.5K
Rational Design of a Shortened Electron Transfer Pathway in P450BM3 for Enhanced Hydroxylation Catalysis
Qingbo Deng1, Yinghui Feng2, Zhen-Ming Lu1
1School of Biotechnology, Jiangnan University, Wuxi 214126, People's Republic of China.
Journal of Agricultural and Food Chemistry
|August 20, 2025
Summary
Researchers elucidated the electron transfer mechanism in cytochrome P450 enzymes, crucial for steroid hormone synthesis. Engineering shorter pathways significantly boosted enzyme efficiency for drug development.
Area of Science:
- Biochemistry
- Enzymology
- Drug Synthesis
Background:
- Cytochrome P450 enzymes are vital for synthesizing steroid hormones, the second-largest drug class.
- Current limitations in practical application stem from low electron transfer (ET) efficiency due to an unclear intramolecular ET mechanism.
Purpose of the Study:
- To elucidate the authentic intramolecular electron transfer mechanism in P450BM3.
- To enhance P450BM3 catalytic performance through cofactor engineering and pathway optimization.
Main Methods:
- Utilized cryo-electron microscopy (cryo-EM) to resolve two P450BM3 conformations (closed and open).
- Proposed a novel "interchain same-side" electron transfer mechanism.
- Employed cofactor engineering and pathway shortening strategies to create enhanced enzyme variants.
Main Results:
- The proposed "interchain same-side" ET mechanism involves specific domain positioning across P450BM3 dimer chains.
- Mutant M5 demonstrated a 4.43-fold increase in enzyme activity and a 61.43-fold increase in ET rate.
- Mutant M5 exhibited an 11-fold increase in catalytic efficiency (kcat/Km) and a 3.94-fold increase in coupling efficiency (CE).
Conclusions:
- Achieved the first elucidation of the authentic ET mechanism in P450BM3.
- Demonstrated that rational design of shortened ET pathways significantly enhances catalytic performance.
- Established a foundation for the efficient synthesis of hydroxylated steroid drugs.
Related Concept Videos
02:17Reduction of Alkenes: Asymmetric Catalytic Hydrogenation
3.4K
Catalytic hydrogenation of alkenes is a transition-metal catalyzed reduction of the double bond using molecular hydrogen to give alkanes. The mode of hydrogen addition follows syn stereochemistry.
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
3.4K
03:08Hydroboration-Oxidation of Alkenes
8.9K
In addition to the oxymercuration–demercuration method, which converts the alkenes to alcohols with Markovnikov orientation, a complementary hydroboration-oxidation method yields the anti-Markovnikov product. The hydroboration reaction, discovered in 1959 by H.C. Brown, involves the addition of a B–H bond of borane to an alkene giving an organoborane intermediate. The oxidation of this intermediate with basic hydrogen peroxide forms an alcohol.
8.9K
02:36Regioselectivity and Stereochemistry of Hydroboration
8.4K
A significant aspect of hydroboration–oxidation is the regio- and stereochemical outcome of the reaction.
Hydroboration proceeds in a concerted fashion with the attack of borane on the π bond, giving a cyclic four-centered transition state. The –BH2 group is bonded to the less substituted carbon and –H to the more substituted carbon. The concerted nature requires the simultaneous addition of –H and –BH2 across the same face of the alkene giving syn...
Hydroboration proceeds in a concerted fashion with the attack of borane on the π bond, giving a cyclic four-centered transition state. The –BH2 group is bonded to the less substituted carbon and –H to the more substituted carbon. The concerted nature requires the simultaneous addition of –H and –BH2 across the same face of the alkene giving syn...
8.4K
02:13Reduction of Alkenes: Catalytic Hydrogenation
12.5K
Alkenes undergo reduction by the addition of molecular hydrogen to give alkanes. Because the process generally occurs in the presence of a transition-metal catalyst, the reaction is called catalytic hydrogenation.
Metals like palladium, platinum, and nickel are commonly used in their solid forms — fine powder on an inert surface. As these catalysts remain insoluble in the reaction mixture, they are referred to as heterogeneous catalysts.
The hydrogenation process takes place on the...
Metals like palladium, platinum, and nickel are commonly used in their solid forms — fine powder on an inert surface. As these catalysts remain insoluble in the reaction mixture, they are referred to as heterogeneous catalysts.
The hydrogenation process takes place on the...
12.5K
02:44Oxidation of Alkenes: Syn Dihydroxylation with Osmium Tetraoxide
10.8K
Alkenes are converted to 1,2-diols or glycols through a process called dihydroxylation. It involves the addition of two hydroxyl groups across the double bond with two different stereochemical approaches, namely anti and syn. Dihydroxylation using osmium tetroxide progresses with syn stereochemistry.
10.8K
01:17Drug Metabolism: Phase I Reactions
3.6K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
3.6K